These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6394659)

  • 1. [Experimental study upon platelet preservation by prostaglandin I2 during extracorporeal circulation].
    Osada H; Kawada T; Hoson M; Funaki S; Arase K; Masaki H; Taira Y; Kuwahara M; Noguchi T
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Oct; 32(10):1795-803. PubMed ID: 6394659
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of prostaglandin I2 and its derivative in extracorporeal circulation].
    Takeda H; Matsukura H; Kawakami T; Tanabe T
    Kyobu Geka; 1983 Jun; 36(6):479-84. PubMed ID: 6355587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of prostaglandin I2 derivative infusion during experimental cardiopulmonary bypass].
    Matsukura H; Takeda H; Uzawa S; Sakai K; Kawakami T; Tanabe T
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Jun; 31(6):871-5. PubMed ID: 6352833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental studies of the preservation platelet during extracorporeal circulation].
    Matsukura H; Uzawa S; Goda T; Takeda H; Sakai K; Kawakami T; Tanabe T
    Kyobu Geka; 1983 Dec; 36(11):890-2. PubMed ID: 6656030
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a thromboxane synthetase inhibitor for the protection of platelet number and function during extracorporeal circulation. Experimental study].
    Massonnet Castel S; Pelissier E; Fabiani JN; Terrier E
    Agressologie; 1983 Dec; 24(12):605-8. PubMed ID: 6686919
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
    Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
    Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
    Takeda H
    Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased platelet sensitivity to prostacyclin (epoprostenol) during hemodialysis.
    Kristensen SD; Knudsen F; Nielsen AH; Ring T
    Clin Nephrol; 1984 Apr; 21(4):230-4. PubMed ID: 6375926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
    Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator.
    Addonizio VP; Strauss JF; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1979 Jan; 77(1):119-26. PubMed ID: 102876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
    Kerins DM; Murray R; FitzGerald GA
    Prog Hemost Thromb; 1991; 10():307-37. PubMed ID: 1848945
    [No Abstract]   [Full Text] [Related]  

  • 13. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost (ZK36374), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation.
    Addonizio VP; Fisher CA; Jenkin BK; Strauss JF; Musial JF; Edmunds LH
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):926-33. PubMed ID: 2582210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PGI2 infusion during long term extracorporeal circulation with membrane lung in sheep.
    Uziel L; Agostoni A; Pirovano E; Pesenti A; Pelizzola A; Gattinoni L; Galmarini D
    Int J Artif Organs; 1981 May; 4(3):142-5. PubMed ID: 7024139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of platelets during extracorporeal circulation with prostaglandin E1.
    Addonizio VP; Macarak EJ; Niewiarowski S; Colman RW; Edmunds LH
    Trans Am Soc Artif Intern Organs; 1977; 23():639-45. PubMed ID: 910394
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterologous desensitization of platelet adenosine (A2) responses by iloprost.
    MacDermot J; Wilkins AJ; Edwards RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():479-81. PubMed ID: 2444081
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2.
    Bloom A; Hannaford PA; Greaves M; Preston FE; Brown CB
    Clin Nephrol; 1985 Feb; 23(2):85-8. PubMed ID: 3886228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intrainfusion rebound platelet activation during continuous prostaglandin I2 infusion occurs at the receptor level.
    Sinzinger H; Steurer G; Fitscha P; Kraupp O
    Prog Clin Biol Res; 1987; 242():19-23. PubMed ID: 2444986
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.